Many are bizarre and live in salt lakes, hydrothermal vents and other extreme environments.

Roundworms harbor viruses, which could be responsible for these parasites' painful symptoms in humans, scientists theorize.

Cambridge’s Camp4 Therapeutics Inc. and Waltham’s Upstream Bio Inc. will both make their debuts on the public markets Friday.

A startup licensing a biotech invention from Ohio State has launched from stealth mode with a record Series A for university ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under ...

Studying the secrets of how the common red milkweed beetle can safely feed on a toxic plant helps illuminate the ecological, evolutionary and economic impact of insect-plant interactions from a ...

Titan likely has the rich chemistry to jumpstart life. But the question is whether its suspected subsurface ocean is simply ...

Retired judge finds serious corruption in COVID-19 procurement process, recommends recovery of ₹500 crore from suppliers.

In a recently published article in Nature Communications, a team of researchers from the University of Virginia -; including Phil Bourne, dean of the School of Data Science, Cam Mura, a senior ...

Victor Ambros, an American developmental biologist, has been awarded the 2024 Nobel Prize in Physiology or Medicine alongside ...

CAMP4 Therapeutics (NASDAQ:CAMP) priced its IPO of 6.82M shares at an initial public offering price of $11.00 per share. The gross proceeds are expected to be ~$75M. CAMP4’s common stock is expected ...